4:21 PM
 | 
Aug 29, 2013
 |  BC Extra  |  Company News

EC approves new Eylea indication

The European Commission approved an MAA from Bayer AG (Xetra:BAYN) to expand the label of Eylea aflibercept to include treatment of visual impairment due to...

Read the full 111 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Extra

Article Purchase

$35 USD
More Info >